0001104659-17-043682.txt : 20170705 0001104659-17-043682.hdr.sgml : 20170705 20170705201511 ACCESSION NUMBER: 0001104659-17-043682 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics Plc CENTRAL INDEX KEY: 0001703287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 6108166640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Plc DATE OF NAME CHANGE: 20170407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crotty Robert CENTRAL INDEX KEY: 0001600253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38132 FILM NUMBER: 17950577 MAIL ADDRESS: STREET 1: 1301 2ND AVE CITY: SEATTLE STATE: WA ZIP: 98101 4 1 a4.xml 4 X0306 4 2017-06-30 0 0001703287 Nabriva Therapeutics Plc NBRV 0001600253 Crotty Robert 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 General Counsel & Corp Secreta Stock Option 2017-06-30 4 A 0 90000 0.00 A 2027-06-30 Ordinary Shares 90000 90000 D The exercise price is $10.48 per share. This option was granted on June 30, 2017. Vesting will begin on June 30, 2017 and end on June 30, 2021. Twenty-five percent (25%) of the option will vest on June 30, 2018, and the remaining seventy-five percent (75%) will vest on a monthly pro-rata basis over the remaining vesting period. /s/ Robert Crotty 2017-07-05